ISSN 1673-3770 CN 37-1437/R
Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2026, Vol. 40 ›› Issue (6): 91-99.
• Airway Allergic Diseases: From Mechanism to Practice • Previous Articles
WU Yujie, ZHU Xiaoyan, WANG Xu
CLC Number:
| [1] Lourijsen E S, Fokkens W J, Reitsma S. Direct and indirect costs of adult patients with chronic rhinosinusitis with nasal polyps[J]. Rhinology, 2020, 58(3): 213-217. DOI:10.1002/lary.27852 [2] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 慢性鼻窦炎诊断和治疗指南(2024)[J]. 中华耳鼻咽喉头颈外科杂志, 2025, 60(3): 221-249.DOI: 10.3760/cma.j.cn115330-20250116-00051 [3] Fokkens W J, Lund V J, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020[J]. Rhinology, 2020, 58(29): 1-464. DOI:10.4193/Rhin20.600 [4] Leigh M W, Pittman J E, Carson J L, et al. Clinical and genetic aspects of primary ciliary dyskinesia/Kartagener syndrome[J]. Genet Med, 2009, 11(7): 473-487. DOI:10.1097/GIM.0b013e3181a53562 [5] Psaltis A J, MacKenzie B W, Cope E K, et al. Unraveling the role of the microbiome in chronic rhinosinusitis[J]. J Allergy Clin Immunol, 2022, 149(5): 1513-1521. DOI:10.1016/j.jaci.2022.02.022 [6] Yan B, Lan F, Li J Y, et al. The mucosal concept in chronic rhinosinusitis: Focus on the epithelial barrier[J]. J Allergy Clin Immunol, 2024, 153(5): 1206-1214. DOI:10.1016/j.jaci.2024.01.015 [7] Zhang N, Van Crombruggen K, Gevaert E, et al. Barrier function of the nasal mucosa in health and type-2 biased airway diseases[J]. Allergy, 2016, 71(3): 295-307. DOI:10.1111/all.12809 [8] Kato A, Schleimer R P, Bleier B S. Mechanisms and pathogenesis of chronic rhinosinusitis[J]. J Allergy Clin Immunol, 2022, 149(5): 1491-1503. DOI:10.1016/j.jaci.2022.02.016 [9] Delemarre T, Bochner B S, Simon H U, et al. Rethinking neutrophils and eosinophils in chronic rhinosinusitis[J]. J Allergy Clin Immunol, 2021, 148(2): 327-335. DOI:10.1016/j.jaci.2021.03.024 [10] 王蕾, 王威清, 奥登苏日塔, 等. 基于质谱流式技术分析慢性鼻窦炎伴鼻息肉的免疫微环境细胞构成特征[J]. 中华耳鼻咽喉头颈外科杂志, 2024, 59(6): 532-542. DOI:10.3760/cma.j.cn115330-20240210-00085 [11] Krysko O, Holtappels G, Zhang N, et al. Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis[J]. Allergy, 2011, 66(3): 396-403. DOI:10.1111/j.1398-9995.2010.02498.x [12] Persson E K, Verstraete K, Heyndrickx I, et al. Protein crystallization promotes type 2 immunity and is reversible by antibody treatment[J]. Science, 2019, 364(6442): eaaw4295. DOI:10.1126/science.aaw4295 [13] Ordovas-Montanes J, Beyaz S, Rakoff-Nahoum S, et al. Distribution and storage of inflammatory memory in barrier tissues[J]. Nat Rev Immunol, 2020, 20(5): 308-320. DOI:10.1038/s41577-019-0263-z [14] Natoli G, Ostuni R. Adaptation and memory in immune responses[J]. Nat Immunol, 2019, 20(7): 783-792. DOI:10.1038/s41590-019-0399-9 [15] Kabat A M, Pearce E J. Inflammation by way of macrophage metabolism[J]. Science, 2017, 356(6337): 488-489. DOI:10.1126/science.aan2691 [16] Eckardt K U. Oxygen sensing and cell metabolism in inflammation[J]. Nat Rev Nephrol, 2017, 13(12): 727-728. DOI:10.1038/nrneph.2017.145 [17] Qin Z W, Chen Y J, Wang Y, et al. Immunometabolism in the pathogenesis of asthma[J]. Immunology, 2024, 171(1): 1-17. DOI:10.1111/imm.13688 [18] Xie S, Zhang C, Xie Z, et al. Serum metabolomics identifies uric acid as a possible novel biomarker for predicting recurrence of chronic rhinosinusitis with nasal polyps[J]. Rhinology, 2023, 61(6): 541-551. DOI:10.4193/Rhin23.236 [19] Li J X, Wang Z Z, Zhai G T, et al. Untargeted metabolomic profiling identifies disease-specific and outcome-related signatures in chronic rhinosinusitis[J]. J Allergy Clin Immunol, 2022, 150(3): 727-735.e6. DOI:10.1016/j.jaci.2022.04.006 [20] Vander Heiden M G, Cantley L C, Thompson C B. Understanding the Warburg effect: the metabolic requirements of cell proliferation[J]. Science, 2009, 324(5930): 1029-1033. DOI:10.1126/science.1160809 [21] Qian X, Aboushousha R, van de Wetering C, et al. IL-1/inhibitory κB kinase ε-induced glycolysis augment epithelial effector function and promote allergic airways disease[J]. J Allergy Clin Immunol, 2018, 142(2): 435-450.e10. DOI:10.1016/j.jaci.2017.08.043 [22] Schwärzler J, Mayr L, Grabherr F, et al. Epithelial metabolism as a rheostat for intestinal inflammation and malignancy[J]. Trends Cell Biol, 2024, 34(11): 913-927. DOI:10.1016/j.tcb.2024.01.004 [23] Chen C L, Ma J, Lu R Y, et al. Perturbated glucose metabolism augments epithelial cell proinflammatory function in chronic rhinosinusitis[J]. J Allergy Clin Immunol, 2023, 151(4): 991-1004.e20. DOI:10.1016/j.jaci.2022.09.036 [24] Bearham J, Garnett J P, Schroeder V, et al. Effective glucose metabolism maintains low intracellular glucose in airway epithelial cells after exposure to hyperglycemia[J]. Am J Physiol Cell Physiol, 2019, 317(5): C983-C992. DOI:10.1152/ajpcell.00193.2019 [25] Huang G X, Mandanas M V, Djeddi S, et al. Increased glycolysis and cellular crosstalk in eosinophilic chronic rhinosinusitis with nasal polyps[J]. Front Immunol, 2024, 15: 1321560. DOI:10.3389/fimmu.2024.1321560 [26] Huang S Y, Shi J H, Shen J F, et al. Metabolic reprogramming of neutrophils in the tumor microenvironment: Emerging therapeutic targets[J]. Cancer Lett, 2025, 612: 217466. DOI:10.1016/j.canlet.2025.217466 [27] Zhou Y P, Cao C, Li R R, et al. Metabolism: a potential regulator of neutrophil fate[J]. Front Immunol, 2024, 15: 1500676. DOI:10.3389/fimmu.2024.1500676 [28] Zhang Q, Wang J L, Yadav D K, et al. Glucose metabolism: the metabolic signature of tumor associated macrophage[J]. Front Immunol, 2021, 12: 702580. DOI:10.3389/fimmu.2021.702580 [29] Liu Y, Xu R Y, Gu H Y, et al. Metabolic reprogramming in macrophage responses[J]. Biomark Res, 2021, 9(1): 1. DOI:10.1186/s40364-020-00251-y [30] Freemerman A J, Johnson A R, Sacks G N, et al. Metabolic reprogramming of macrophages[J]. J Biol Chem, 2014, 289(11): 7884-7896. DOI:10.1074/jbc.m113.522037 [31] Haas R, Smith J, Rocher-Ros V, et al. Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions[J]. PLoS Biol, 2015, 13(7): e1002202. DOI:10.1371/journal.pbio.1002202 [32] Quehenberger O, Dennis E A. The human plasma lipidome[J]. N Engl J Med, 2011, 365(19): 1812-1823. DOI:10.1056/nejmra1104901 [33] Shimizu T. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation[J]. Annu Rev Pharmacol Toxicol, 2009, 49: 123-150. DOI:10.1146/annurev.pharmtox.011008.145616 [34] Johnson R K, Manke J, Campbell M, et al. Lipid mediators are detectable in the nasal epithelium and differ by asthma status in female subjects[J]. J Allergy Clin Immunol, 2022, 150(4): 965-971.e8. DOI:10.1016/j.jaci.2022.02.026 [35] Fazlollahi F, Kongmanas K, Tanphaichitr N, et al. Lipidomic profiling of sinus mucosa from patients with chronic rhinosinusitis[J]. Clin Transl Sci, 2015, 8(2): 107-115. DOI:10.1111/cts.12256 [36] Ma Y, Wei Y, Liu X, et al. Metabolomics analysis of metabolic patterns in chronic rhinosinusitis with nasal polyps[J]. Allergy, 2022, 77(2): 653-656. DOI:10.1111/all.15179 [37] Yang Y J, Guo J, Yao Y, et al. Proteomics and metabolomics analysis of nasal lavage fluid in chronic rhinosinusitis with nasal polyps[J]. Int Forum Allergy Rhinol, 2023, 13(10): 1966-1970. DOI:10.1002/alr.23151 [38] Pauls S D, Rodway L A, Winter T, et al. Alpha-linolenic acid enhances the phagocytic and secretory functions of alternatively activated macrophages in part via changes to the oxylipin profile[J]. Int J Biochem Cell Biol, 2020, 119: 105662. DOI:10.1016/j.biocel.2019.105662 [39] Gevaert P, Han J K, Smith S G, et al. The roles of eosinophils and interleukin-5 in the pathophysiology of chronic rhinosinusitis with nasal polyps[J]. Int Forum Allergy Rhinol, 2022, 12(11): 1413-1423. DOI:10.1002/alr.22994 [40] Miyata J, Fukunaga K, Kawashima Y, et al. Dysregulated fatty acid metabolism in nasal polyp-derived eosinophils from patients with chronic rhinosinusitis[J]. Allergy, 2019, 74(6): 1113-1124. DOI:10.1111/all.13726 [41] Wang Z C, Yao Y, Wang N, et al. Deficiency in interleukin-10 production by M2 macrophages in eosinophilic chronic rhinosinusitis with nasal polyps[J]. Int Forum Allergy Rhinol, 2018, 8(11): 1323-1333. DOI:10.1002/alr.22218 [42] Liu C, Wang K H, Liu W Q, et al. ALOX15(+)M2 macrophages contribute to epithelial remodeling in eosinophilic chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol, 2024, 154(3): 592-608. DOI:10.1016/j.jaci.2024.04.019 [43] Arita M. Eosinophil polyunsaturated fatty acid metabolism and its potential control of inflammation and allergy[J]. Allergol Int, 2016, 65 Suppl: S2-S5. DOI:10.1016/j.alit.2016.05.010 [44] Brennan E, Kantharidis P, Cooper M E, et al. Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function[J]. Nat Rev Nephrol, 2021, 17(11): 725-739. DOI:10.1038/s41581-021-00454-y [45] 朱真真, 王威清, 韩晋博, 等. 特异性促炎症消退介质在嗜酸粒细胞性与非嗜酸粒细胞性慢性鼻窦炎伴鼻息肉中的含量差异[J]. 中华耳鼻咽喉头颈外科杂志, 2021, 56(10): 1073-1079. DOI:10.3760/cma.j.cn115330-20210419-00212 [46] Kao S S, Bassiouni A, Ramezanpour M, et al. Proteomic analysis of nasal mucus samples of healthy patients and patients with chronic rhinosinusitis[J]. J Allergy Clin Immunol, 2021, 147(1): 168-178. DOI:10.1016/j.jaci.2020.06.037 [47] Li M L, Qin J F, Xiong K, et al. Review of arginase as a promising biocatalyst: characteristics, preparation, applications and future challenges[J]. Crit Rev Biotechnol, 2022, 42(5): 651-667. DOI:10.1080/07388551.2021.1947962 [48] Dweik R A, Boggs P B, Erzurum S C, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels(FENO)for clinical applications[J]. Am J Respir Crit Care Med, 2011, 184(5): 602-615. DOI:10.1164/rccm.9120-11ST [49] Lee D J, Yip J, Lee J M. Nasal nitric oxide as a long-term monitoring and prognostic biomarker of mucosal health in chronic rhinosinusitis[J]. Int Forum Allergy Rhinol, 2020, 10(8): 971-977. DOI:10.1002/alr.22581 [50] Bommarito L, Guida G, Heffler E, et al. Nasal nitric oxide concentration in suspected chronic rhinosinusitis[J]. Ann Allergy Asthma Immunol, 2008, 101(4): 358-362. DOI:10.1016/S1081-1206(10)60310-9 [51] Luiking Y C, Ten Have G A M, Wolfe R R, et al. Arginine de novo and nitric oxide production in disease states[J]. Am J Physiol Endocrinol Metab, 2012, 303(10): E1177-E1189. DOI:10.1152/ajpendo.00284.2012 [52] Vlad D, Albu S. Arginase isoform expression in chronic rhinosinusitis[J]. J Clin Med, 2019, 8(11): 1809. DOI:10.3390/jcm8111809 [53] Kishton R J, Sukumar M, Restifo N P. Arginine arms T cells to thrive and survive[J]. Cell Metab, 2016, 24(5): 647-648. DOI:10.1016/j.cmet.2016.10.019 [54] Kagoya Y, Saijo H, Matsunaga Y, et al. Arginine methylation of FOXP3 is crucial for the suppressive function of regulatory T cells[J]. J Autoimmun, 2019, 97: 10-21. DOI:10.1016/j.jaut.2018.09.011 [55] Rath M, Müller I, Kropf P, et al. Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages[J]. Front Immunol, 2014, 5: 532. DOI:10.3389/fimmu.2014.00532 [56] Han X Y, He X J, Zhan X J, et al. Disturbed microbiota-metabolites-immune interaction network is associated with olfactory dysfunction in patients with chronic rhinosinusitis[J]. Front Immunol, 2023, 14: 1159112. DOI:10.3389/fimmu.2023.1159112 [57] Chen F, Gao W X, Yu C S, et al. Age-associated changes of nasal bacterial microbiome in patients with chronic rhinosinusitis[J]. Front Cell Infect Microbiol, 2022, 12: 786481. DOI:10.3389/fcimb.2022.786481 [58] Cope E K, Goldberg A N, Pletcher S D, et al. Compositionally and functionally distinct sinus microbiota in chronic rhinosinusitis patients have immunological and clinically divergent consequences[J]. Microbiome, 2017, 5(1): 53. DOI:10.1186/s40168-017-0266-6 [59] Giudetti A M, De Domenico S, Ragusa A, et al. A specific lipid metabolic profile is associated with the epithelial mesenchymal transition program[J]. Biochim Biophys Acta Mol Cell Biol Lipids, 2019, 1864(3): 344-357. DOI:10.1016/j.bbalip.2018.12.011 [60] Dong C F, Yuan T T, Wu Y D, et al. Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer[J]. Cancer Cell, 2013, 23(3): 316-331. DOI:10.1016/j.ccr.2013.01.022 [61] Jo M S, Yang H W, Park J H, et al. Glycolytic reprogramming is involved in tissue remodeling on chronic rhinosinusitis[J]. PLoS One, 2023, 18(2): e0281640. DOI:10.1371/journal.pone.0281640 [62] Wu S Y, Cai B Y, Cao Z W, et al. Sirt5 affects the metabolic remodeling of eosinophils by negatively regulating the level of succinylation modification of Pkm2 in eosinophilic chronic rhinosinusitis[J]. World J Otorhinolaryngol Head Neck Surg, 2024, 11(1): 86-101. DOI:10.1002/wjo2.186 [63] Zhou B, Jiang G T, Liu H, et al. Dysregulated arginine metabolism in young patients with chronic persistent asthma and in human bronchial epithelial cells[J]. Nutrients, 2021, 13(11): 4116. DOI:10.3390/nu13114116 [64] Yan B, Wang Y, Li Y, et al. Inhibition of arachidonate 15-lipoxygenase reduces the epithelial-mesenchymal transition in eosinophilic chronic rhinosinusitis with nasal polyps[J]. Int Forum Allergy Rhinol, 2019, 9(3): 270-280. DOI:10.1002/alr.22243 [65] Marques R M, Gonzalez-Nunez M, Walker M E, et al. Loss of 15-lipoxygenase disrupts T(reg)differentiation altering their pro-resolving functions[J]. Cell Death Differ, 2021, 28(11): 3140-3160. DOI:10.1038/s41418-021-00807-x [66] Kristjansson R P, Benonisdottir S, Davidsson O B, et al. A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis[J]. Nat Genet, 2019, 51(2): 267-276. DOI:10.1038/s41588-018-0314-6 [67] Li Z P, Zeng M, Deng Y H, et al. 15-Lipoxygenase 1 in nasal polyps promotes CCL26/eotaxin 3 expression through extracellular signal-regulated kinase activation[J]. J Allergy Clin Immunol, 2019, 144(5): 1228-1241.e9. DOI:10.1016/j.jaci.2019.06.037 |
| [1] | ZHOU Jiayao, ZHU Ying, HU Huilin, LI Zhipeng, LIN Hai, TANG Ru, MAO Song, GU Yuelong, ZHAO Yue, ZHANG Weitian. Nasal epithelial cell injury and fibroblast inflammatory phenotype activation induced by PM2.5 organic components [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(6): 10-21. |
| [2] | LIANG Shaoqin, LIN Xinsheng, LI Jiajia. Effects of a three-dimensional intervention based on the health belief model on chronic rhinosinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(6): 30-39. |
| [3] | WANG Yunuo, LI Zhenglin, ZHAO Jiaxian, LI Wenkai, LU Hui, WU Jingfang, XUE Gang. The correlation between the expression of IL-8, IFN-γ and systemic inflammatory index in CRSwNP patients and its clinical significance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(6): 46-53. |
| [4] | SU Yilin, XUE Jinmei. Mechanism of telomere dysfunction inducing ROS-promoted airway Th2-type inflammation [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(6): 70-75. |
| [5] | JIANG Yue, GU Yajun, WANG Junguo, QIAN Xiaoyun. Advances in metabolomics for pediatric obstructive sleep apnea-hypopnea syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(5): 18-24. |
| [6] | ZHU Bin, LIU Di, JIAO Cheng, YAN Qi, WANG Ying, GUAN Bing, MA Wei, XU Li, CAO Qing. The current situation and frontiers of chronic sinusitis research in children: visual analysis based on CiteSpace [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(5): 37-52. |
| [7] | WU Bo, YAN Bin, TANG Yong. Evaluation of postoperative efficacy and analysis of prognostic factors in chronic sinusitis patients undergoing functional endoscopic sinus surgery in the "internet+"medical model [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(5): 94-102. |
| [8] | XIANG Lan, GU Jia, QIN Qing, LIU Xuewei, ZHAO Xuezhang. Analysis of the efficacy of high-concentration glucocorticoid-soaked gelatin sponge nasal packing after endoscopic surgery for chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(4): 37-44. |
| [9] | FENG Sicong, YU Xiaolan, LOU Dan. Evaluation of the effect of Messerklinger middle turbinate plasty on chronic rhinosinusitis with nasal polyps based on the expression of Ki67 and GM-CSF in vesicular tissue [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 31-39. |
| [10] | ZHAI Xuechun, BIAN Xin, CHEN Jingcai, DENG Jiayu, YE Zi, YANG Pingli. Characteristics and influencing factors of anxiety and depression in patients with chronic frontal sinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(2): 35-43. |
| [11] | LI Yangsong, YUAN Fayang, YANG Yan, ZHANG Tian, YU Guodong. Bibliometric analysis of biologic agents for the treatment of chronic rhinosinusitis based on the Web of Science database [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 54-64. |
| [12] | ZHANG Jiaqi, YUAN Ye, HONG Chen, GU Min, CHENG Lei, LU Meiping. Mendelian randomization study of gut microbiota, chronic sinusitis, and nasal polyps: Causal relationships and metabolite-mediated effects [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 49-60. |
| [13] | ZHENG Zehao, WEI Jiali, LIU Jiatao, ZHOU Yuqi, SUN Wenting, LI Yuxuan, BAI Peng. Evaluation of the efficacy and safety of site-specific acupuncture for the treatment of sudden hearing loss: a systematic review and network Meta-analysis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 114-127. |
| [14] | ZHANG Guangling, CHEN Xingxue, WU Tianyi, SUN Zhanwei, WANG Weiwei, LI Shichao,WANG Guangke. The expression and function of Tespa1 in chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 35-42. |
| [15] | CAO Zhengyong, LI Xiaobo. Comparison of the safety and efficacy of short-course postoperative topical glucocorticoid adjuvant therapy for eCRSwNP combined with asthma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 43-50. |
|
||